Mylan Pharmaceuticals Inc. recalls a lot of the anti-anxiety medication alprazolam – often sold under the brand name Xanax – "because of the potential presence of a foreign drug," the company said last week.
the likelihood of someone getting sick "is expected to be rare, but the remote risk of infection in a patient cannot be ruled out." Mylan added that no adverse events were reported as of Friday's announcement. to that particular party.
Mylan refused to provide further information about the product or the foreign substance.
The voluntary recall includes a single batch of bottles, each containing 500 0.5 mg tablets, distributed in the United States between July and August. The number affected was 8082708, and the expiry date is listed as September 2020.
Instructions for wholesalers, dealers and consumers to return recalled bottles can be found in the company's announcement, which was also sent to the US Food and Drug Administration & # 39 ; s website. Adverse events can be reported to the agency's MedWatch program for reporting adverse events.